China National Accord Medicines (SZSE:000028) ROCE %: 8.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000028 China National Accord Medicines Corp Ltd SZSE:000028
57 GF Score
Price ¥20.00
! 6 Warning Signs
View Full Analysis

What is China National Accord Medicines ROCE %?

China National Accord Medicines SZSE:000028 +1.01% 57 ROCE % is 8.40% as of Jun. 2026. GuruFocus rates SZSE:000028 with a GF Score™ of 57/100. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China National Accord Medicines's annualized ROCE % for the quarter that ended in Jun. 2026 was 8.40%.

China National Accord Medicines  (SZSE:000028) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China National Accord Medicines ROCE % Related Terms

China National Accord Medicines ROCE % Historical Data

* Premium members only.

The historical data trend for China National Accord Medicines's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines ROCE % Chart

China National Accord Medicines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.39 12.25 12.14 3.63 7.45

China National Accord Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.18 7.64 4.42 7.10 8.40
SZSE:000028
57GF Score
China National Accord Medicines Corp Ltd SZSE:000028
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Accord Medicines ROCE % Calculation

China National Accord Medicines's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1703.518/( ( (47555.86 - 24802.407) + (49096.271 - 26105.143) )/ 2 )
=1703.518/( (22753.453+22991.128)/ 2 )
=1703.518/22872.2905
=7.45 %

China National Accord Medicines's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=1949.512/( ( (49123.776 - 25897.592) + (48170.514 - 25003.504) )/ 2 )
=1949.512/( ( 23226.184 + 23167.01 )/ 2 )
=1949.512/23196.597
=8.40 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.40% mean?
China National Accord Medicines (SZSE:000028) has a ROCE % of 8.40% as of Jun. 2026.
Is China National Accord Medicines' ROCE % too high?
China National Accord Medicines' current ROCE % is 8.40%. The Medical Distribution industry median ROCE % is 8.83. China National Accord Medicines' value of 8.40% is 4.8% below this industry median. Overall, China National Accord Medicines has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' ROCE % compare to MCK and COR?
China National Accord Medicines' ROCE % of 8.40% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.83. China National Accord Medicines' value of 8.40% is 4.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.83, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Accord Medicines's current ROCE % of 8.40% is 4.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Accord Medicines's current ROCE % is 8.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
China National Accord Medicines (SZSE:000028) has a current ROCE % of 8.40%. The current ROCE % is 8.40% and 4.8% below the Medical Distribution industry median of 8.83. China National Accord Medicines' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For China National Accord Medicines (SZSE:000028), the current ROCE % is 8.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China National Accord Medicines Business Description

Other Exchanges 200028:China
Address No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
57GF Score

Get the complete analysis for SZSE:000028

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.00
Price